Philips North America: A Court Order Over the Defibrillator Business

The Massachusetts federal court entered the Philips North America defibrillator consent decree in 2017, restricting the company’s defibrillator manufacturing. The order reached beyond a correction on paper: restarting restricted production required the Food and Drug Administration’s written approval. Philips had to pay for an independent expert to examine the work.

Philips North America LLC operated under the names Philips Medical Systems and Philips Healthcare. The Massachusetts court decree bound two individual defendants as well as the company. For a quality or engineering employee, the practical question was whether the corrections addressed the problem well enough for production to resume.

What the Government Said Went Wrong

The government’s case rested on two 2015 Food and Drug Administration inspections. At Philips’ Bothell, Washington facility, the inspection found inadequate procedures for corrective and preventive action. The complaint alleged that Philips began corrective action after complaints of resistor failures during use of the HeartStart HS1 and FRx defibrillators, but that the corrections did not fully address the problem with devices in the field and the complaints continued. At the Andover, Massachusetts facility, the government alleged inadequate procedures for the Q-CPR meter, which gives feedback on chest compressions during cardiopulmonary resuscitation, and for design verification of a battery change in the HeartStart MRx defibrillator.

The order required Philips to send notifications about the Q-CPR meters and the external defibrillators built with the resistor at issue. A covered defibrillator still under warranty was to be exchanged for a refurbished unit at no cost; a customer whose device was out of warranty might qualify for a trade-in rebate.

The Court Order Reached the Factory

The Philips decree put an outside expert and the Food and Drug Administration between the company’s corrective work and a restart. The company bore the expert’s cost, and the order preserved a channel for medically necessary devices while manufacturing restrictions operated.

That exception matters in health care. Stopping a device business affects the people who rely on its products as well as the manufacturer. The work inside the company still had to satisfy the outside review and the agency’s written decision.

The decree specified $15,000 per action, per business day in preset damages for noncompliance. The amount applied to a missed obligation under the order. It put a daily cost alongside the restriction on production, with the company responsible for both the corrective work and the independent review.

For someone working on that correction, the test result and the decision to accept it are different parts of the story. We examine the response to warnings, what an outside expert recommended and what management did next. The employee who knows why a proposed fix was accepted or rejected can explain what a finished correction record alone leaves unclear.

The Quality Records Behind a Device Problem

A device manufacturer’s complaint files can hold both the incoming report of a failure and the company’s decision about reporting it. That makes the internal response as important to understanding a problem as the complaint itself.

Manufacturers receive serious-injury reports from healthcare facilities that know who made the device, and malfunction reports from importers. For the quality employee reviewing those reports, the complaint history can be broader than the account that reaches the regulator. Testing and trend analysis also inform what the company knows about a device’s performance.

The decision to leave an event unreported has a documentary history of its own. The incoming complaint, the test results and the internal conclusion may tell different parts of the same story. Your knowledge of why a decision changed, or why it did not, can make those documents intelligible.

This is where a device insider’s account matters to our work. We examine the company’s response with you, including what it learned from repeated complaints and whether sales continued. The question is how the business used the information it had about the product patients would receive.

What Kind of Proof Is Needed to Be a Whistleblower?

The key evidence is documents that tie a known device problem to a government purchase or payment claim. We work through those records with you. Your knowledge of the product and the company’s decisions gives that assessment its starting point.

Quality staff may understand a failure that sales staff saw only as a customer complaint. Reimbursement or billing staff may see another part of the transaction. We bring those connections into the assessment of a medical device fraud case, including what the government paid for and what the company supplied.

Where a replacement or credit is involved, we assess the manufacturer’s records alongside the customer’s account and the payment claim. The particular product and payment arrangement matter, and our role is to develop the case with the people who understand what happened inside the business.

A separate whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We assess that possibility against the specific government-payment evidence you bring us.

A Defibrillator Case That Reached False Claims

In St. Jude Medical’s battery case, the company agreed to pay $27 million in 2021 to resolve allegations that it sold defective implantable defibrillators while withholding known battery-related injuries and a death from the Food and Drug Administration.

The Separate Respironics Decree

Philips Respironics faced a separate recall-remediation and manufacturing decree in 2024. That order treated devices subject to the earlier defibrillator decree separately. Its recall-remediation obligations concerned the respiratory business, while this page’s court order concerned defibrillators.

You Know How the Company Responded

If you saw a device problem move from a complaint into a decision to keep selling, your account can show us how the business made that choice. We work alongside you throughout the case and bring in medical device whistleblower lawyers who understand the connection between product failures, internal knowledge and government payments. Speak with our whistleblower experts about the decision you saw.